2
CME We invite readers to earn Category I Continuing Medical Education (CME) credit each month through the Journal of the American Academy of Child and Adolescent Psychiatry. This opportunity is supported by Elsevier and the American Academy of Child and Adolescent Psychiatry at no cost to the participant. The participant must obtain a score of 70% or greater to earn CME credit. The American Academy of Child and Adolescent Psychiatry is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians. The CME questions for the July 2010 issue of the Journal refer to “Access to Treatment for Adolescents With Substance Use and Co-Occurring Disorders: Challenges and Opportunities,” by Sterling et al. The complete article can be found on page 637 of the July 2010 issue. Subscribers and AACAP members have full-text online access to the article by Sterling et al. Nonsubscribers will need to purchase the article at www.jaacap.org to complete the online assessment examination. Learning Objectives Upon reading this article, readers should be able to: 1. Identify financial and/or payer barriers to accessing treatment by adolescents with alco- hol and drug problems, including those with co-occurring problems. 2. Recognize the clinical and organizational bar- riers to accessing treatment by adolescents with alcohol and drug problems, including those with co-occurring problems. 3. List considerations in analyzing the cost benefits of alcohol and drug services for adolescents. 4. Identify the possible opportunities to improve access for adolescents with alcohol and drug problems in the ongoing reform of health care. CME Questions 1. Which of the following are financial barriers to accessing treatment by adolescents with alco- hol and drug problems? a. Burden of increased patient share of costs via high deductibles and co-payments b. Exclusion of emergency and acute care for adolescents by insurance plans c. Failure of integrated health plans to con- tract with outside agencies for alcohol and drug services d. High-cost treatment by physicians, rather than less expensive care by social workers, psychologists, and other counselors e. Premature treatment of adolescents at early stages of a disorder followed by reduced resources for treatment when disorder is more deleterious 2. Which of the following is an organizational or a clinical barrier to accessing treatment by adolescents with alcohol and drug problems? a. Burden of obtaining specialized referral for mental health treatment versus substance use disorder treatment b. Decreased referrals for appropriate alcohol and drug treatment because of pediatri- cians’ preference to treat adolescent pa- tients in primary care c. Exclusion of co-occurring diagnoses from treatment in both mental health and alcohol and drug programs d. Greater concern by physicians about ado- lescents’ alcohol and marijuana use versus other drugs e. Lack of adequate screening of adolescents for alcohol and drug problems in mental health and primary care settings 3. Which of the following is a consideration in analyzing cost benefits of treating adolescents with alcohol and drug problems? a. The ability to adapt adult cost-effectiveness treatment methods to adolescent treatment b. The importance of looking only at the cost effects of treatment on the patient c. The lack of a reliable cost analysis program d. The importance of not including costs to the family as part of costs to the adolescent in attending treatment e. The optimal timing of the cost analysis to best reflect the economic benefits 4. Which of the following could potentially be an opportunity to improve coordinated care for adolescents with alcohol and drug problems? a. Adoption of more restrictive regulations gov- erning the sharing of confidential personal JOURNAL OF THE AMERICAN ACADEMY OF CHILD & ADOLESCENT PSYCHIATRY VOLUME 49 NUMBER 7 JULY 2010 725 www.jaacap.org

July 2010 CME

  • Upload
    buidiep

  • View
    227

  • Download
    0

Embed Size (px)

Citation preview

Page 1: July 2010 CME

CME

We invite readers to earn Category I Continuing Medical Education (CME) credit each month throughthe Journal of the American Academy of Child and Adolescent Psychiatry.

This opportunity is supported by Elsevier and the American Academy of Child and AdolescentPsychiatry at no cost to the participant. The participant must obtain a score of 70% or greater to earnCME credit.

The American Academy of Child and Adolescent Psychiatry is accredited by the Accreditation Councilfor Continuing Medical Education to sponsor continuing medical education for physicians.

The CME questions for the July 2010 issue of the Journal refer to “Access to Treatment for AdolescentsWith Substance Use and Co-Occurring Disorders: Challenges and Opportunities,” by Sterling et al. Thecomplete article can be found on page 637 of the July 2010 issue. Subscribers and AACAP membershave full-text online access to the article by Sterling et al. Nonsubscribers will need to purchase the

article at www.jaacap.org to complete the online assessment examination.

2

3

4

Learning ObjectivesUpon reading this article, readers should beable to:1. Identify financial and/or payer barriers to

accessing treatment by adolescents with alco-hol and drug problems, including those withco-occurring problems.

2. Recognize the clinical and organizational bar-riers to accessing treatment by adolescentswith alcohol and drug problems, includingthose with co-occurring problems.

3. List considerations in analyzing the costbenefits of alcohol and drug services foradolescents.

4. Identify the possible opportunities to improveaccess for adolescents with alcohol and drugproblems in the ongoing reform of health care.

CME Questions1. Which of the following are financial barriers to

accessing treatment by adolescents with alco-hol and drug problems?a. Burden of increased patient share of costs

via high deductibles and co-paymentsb. Exclusion of emergency and acute care for

adolescents by insurance plansc. Failure of integrated health plans to con-

tract with outside agencies for alcohol anddrug services

d. High-cost treatment by physicians, ratherthan less expensive care by social workers,psychologists, and other counselors

e. Premature treatment of adolescents at earlystages of a disorder followed by reducedresources for treatment when disorder is

more deleterious

JOURNAL OF THE AMERICAN ACADEMY OF CHILD & ADOLESCENT PSYCHIATRY

VOLUME 49 NUMBER 7 JULY 2010

. Which of the following is an organizational ora clinical barrier to accessing treatment byadolescents with alcohol and drug problems?a. Burden of obtaining specialized referral for

mental health treatment versus substanceuse disorder treatment

b. Decreased referrals for appropriate alcoholand drug treatment because of pediatri-cians’ preference to treat adolescent pa-tients in primary care

c. Exclusion of co-occurring diagnoses fromtreatment in both mental health and alcoholand drug programs

d. Greater concern by physicians about ado-lescents’ alcohol and marijuana use versusother drugs

e. Lack of adequate screening of adolescentsfor alcohol and drug problems in mentalhealth and primary care settings

. Which of the following is a consideration inanalyzing cost benefits of treating adolescentswith alcohol and drug problems?a. The ability to adapt adult cost-effectiveness

treatment methods to adolescent treatmentb. The importance of looking only at the cost

effects of treatment on the patientc. The lack of a reliable cost analysis programd. The importance of not including costs

to the family as part of costs to the adolescentin attending treatment

e. The optimal timing of the cost analysis tobest reflect the economic benefits

. Which of the following could potentially be anopportunity to improve coordinated care foradolescents with alcohol and drug problems?a. Adoption of more restrictive regulations gov-

erning the sharing of confidential personal

725www.jaacap.org

Page 2: July 2010 CME

health information between programs, to re-assure patients concerned about stigma

b. Adoption of “pay-for-performance” con-tracting arrangements that focus strictly onpatient outcomes

c. Elimination of contracted or “carved-out”specialty behavioral health treatment pro-

grams

JOURN

726 www.jaacap.org

d. Evaluation of performance measures thatreflect how well health plans identify andrefer adolescents with co-occurring sub-stance and mental health problems

e. Inclusion of universal coverage of mentalhealth and alcohol and drug treatmentservices in current health care reform

legislation

AL OF THE AMERICAN ACADEMY OF CHILD & ADOLESCENT PSYCHIATRY

VOLUME 49 NUMBER 7 JULY 2010